rs70940817
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
This summary comes from the ClinGen Evidence Repository: This missense, c.1960G>A (p.Glu654Lys) variant occurs at an overall allele frequency in gnomAD of 0.0006917 with a MAF of 0.0005056 (138/19954 alleles, including 1 homozygote) in the East Asian population. Computational evidence does not support a deleterious effect on the gene/gene product. This variant meets criteria to be classified as Benign by the ClinGen Platelet Disorders VCEP. GT-specific criteria met: BA1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA8623406/MONDO:0010119/011
Frequency
Consequence
NM_000212.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ITGB3 | ENST00000559488.7 | c.1960G>A | p.Glu654Lys | missense_variant | Exon 12 of 15 | 1 | NM_000212.3 | ENSP00000452786.2 | ||
| ENSG00000259753 | ENST00000560629.1 | n.1924G>A | non_coding_transcript_exon_variant | Exon 12 of 18 | 2 | ENSP00000456711.2 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152120Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000521 AC: 131AN: 251436 AF XY: 0.000464 show subpopulations
GnomAD4 exome AF: 0.000176 AC: 258AN: 1461858Hom.: 1 Cov.: 31 AF XY: 0.000164 AC XY: 119AN XY: 727230 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000204 AC: 31AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74428 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Glanzmann thrombasthenia Benign:2
This missense, c.1960G>A (p.Glu654Lys) variant occurs at an overall allele frequency in gnomAD of 0.0006917 with a MAF of 0.0005056 (138/19954 alleles, including 1 homozygote) in the East Asian population. Computational evidence does not support a deleterious effect on the gene/gene product. This variant meets criteria to be classified as Benign by the ClinGen Platelet Disorders VCEP. GT-specific criteria met: BA1. -
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Glanzmann thrombasthenia;C5442010:Platelet-type bleeding disorder 16 Uncertain:1
- -
ITGB3-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at